Role of Cerebral Venous System in Neurodegenerative Disorders

[1]  Bojana Stefanovic,et al.  Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease. , 2015, Brain : a journal of neurology.

[2]  Jean-Philippe Michaud,et al.  Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. , 2013, Cell reports.

[3]  Hao Wang,et al.  Amyloid-β-induced matrix metalloproteinase-9 secretion is associated with retinal pigment epithelial barrier disruption. , 2013, International journal of molecular medicine.

[4]  D. Radak,et al.  Morphological and haemodynamic abnormalities in the jugular veins of patients with multiple sclerosis , 2012, Phlebology.

[5]  M. Morelli,et al.  The Hypothesis of Pathophysiological Correlation between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis: Rationale of Treatment , 2012, Phlebology.

[6]  Nicolaas I. Bohnen,et al.  White matter lesions in Parkinson disease , 2011, Nature Reviews Neurology.

[7]  Versaci,et al.  Dexamethasone Arterializes Venous Endothelial Cells by Inducing Mitogen-activated Protein Kinase Phosphatase-1 a Novel Antiinflammatory Treatment for Vein Grafts? Clinical Perspective on P 532 Methods Reagents and Antibodies Ecs and Exposure to Flow Silencing of Mkp-1 Transient Transfection Comparat , 2022 .

[8]  A. Minagar,et al.  Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-β1b , 2010, Multiple sclerosis.

[9]  T. Czymai,et al.  Erk5 Activation Elicits a Vasoprotective Endothelial Phenotype via Induction of Krüppel-like Factor 4 (KLF4)* , 2010, The Journal of Biological Chemistry.

[10]  R. Weller,et al.  Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.

[11]  Steve Iliffe,et al.  Alzheimer’s disease , 2009, BMJ : British Medical Journal.

[12]  A. Compston,et al.  Multiple sclerosis , 2008, The Lancet.

[13]  J. Kril,et al.  Neuropathologic correlates of white matter hyperintensities , 2008, Neurology.

[14]  G. Garcı́a-Cardeña,et al.  Regulation of arterial-venous differences in tumor necrosis factor responsiveness of endothelial cells by anatomic context. , 2008, The American journal of pathology.

[15]  A. Minagar,et al.  Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial. , 2008, Archives of neurology.

[16]  J. Boyle,et al.  Statin‐mediated cytoprotection of human vascular endothelial cells: a role for Kruppel‐like factor 2‐dependent induction of heme oxygenase‐1 , 2007, Journal of thrombosis and haemostasis : JTH.

[17]  E. Edelman,et al.  Kruppel-like Factor 4 Regulates Endothelial Inflammation* , 2007, Journal of Biological Chemistry.

[18]  R. Grossman,et al.  Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. , 2005, AJNR. American journal of neuroradiology.

[19]  Zhiyong Lin,et al.  Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells , 2005, Circulation.

[20]  C. D. Sharp,et al.  N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. , 2005, American journal of physiology. Heart and circulatory physiology.

[21]  G. Garcı́a-Cardeña,et al.  Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function , 2005, Circulation research.

[22]  T. Jacob,et al.  Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins. , 2005, Journal of Vascular Surgery.

[23]  A. Minagar,et al.  Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells , 2003, Multiple sclerosis.

[24]  B. Lal,et al.  Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. , 2001, Journal of vascular surgery.

[25]  K. Frei,et al.  Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. , 1999, Journal of cell science.

[26]  L. Naumovski,et al.  Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. , 1999, Circulation.

[27]  D. Carden,et al.  Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. , 1998, American journal of physiology. Heart and circulatory physiology.

[28]  G. Schett,et al.  Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. , 1997, Cell stress & chaperones.

[29]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[30]  C. W. Adams,et al.  PERIVENTRICULAR LESIONS IN MULTIPLE SCLEROSIS: THEIR PERIVENOUS ORIGIN AND RELATIONSHIP TO GRANULAR EPENDYMITIS , 1987, Neuropathology and applied neurobiology.

[31]  T. Oshima,et al.  The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. , 2001, Endothelium : journal of endothelial cell research.

[32]  J. Alexander,et al.  Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.